Scientific Advisory Board


Joseph M Chalil, MD, MBA

SAB Chairman

  • Senior Medical Director, North America, DBV Technologies SA (allergy solutions); Former Boehringer Ingelheim Physician Executive; Expert in US Healthcare policy

  • Chairman of Global Clinical Research and Trial Network; Published in American Journal of Respiratory and Critical Care Medicine

  • Chair, Healthcare Advisory Board & Adjunct Professor, H.Wayne Huizenga College of Business & Entrepreneurship, Nova Southeastern University

  • Dr. Chalil holds three US Patents, and his research includes Clinical Trial Management in Cystic Fibrosis, Multiple Myeloma, and publications in the American Journal of Respiratory and Critical Care Medicine

  • Recipient of the 2013 Outstanding 50 Asian Americans in Business Award


Larry King, CPA, CGMA

SAB Member

  • A proven and effective strategic leader, serial entrepreneur and business builder with over 30 years of extensive experience assisting companies in complex transactions

  • Founded and grew KBA Group, LLP into the largest Dallas based CPA and Advisory firm with a diversified menu of services and led the firm’s strategic growth, both organic and through acquisition. Initiated and constructed the firm’s merger with the tenth largest national CPA firm, and served as the Dallas office Managing Partner post-merger

  • Assisted numerous clients with business strategy, transactions including IPOs, reverse mergers, Special Purpose Acquisition Companies, and mergers and acquisitions from both the buy side and sell side

  • Larry has worked with both domestic and international companies in numerous industries including manufacturing and distribution, technology, software, services, energy, logistics, healthcare, real estate and retail

  • Achievements include the Texas Society of CPAs Lone Star Pathfinder Award; Practical Accountant Practice Innovation Award; Journal of Accountancy Feature Article (regarding Sarbanes-Oxley Compliance) and others

  • CPA, CGMA, BS Accounting and Operations Research graduating (graduating Beta Gamma), Babson College, Wellesley, Mass.


Zach Zachariah, MD

SAB Member

  • Over 40 Years’ experience in cardiology and the healthcare industry, as a physician/cardiologist, policy maker, and academic

  • Head of Cardiology, Holy Cross Hospital; Medical Director of UHealth Cardiology, University of Miami Health System

  • One of the USA’s leading cardiologists; specialties include cardiology, cardiac catheterization, and interventional cardiology; has performed more than 30,000 heart catheterizations and interventional procedures

  • Serves on National Institutes of Health’s (NIH's) National Heart, Lung and Blood Advisory Council (Appointed by HHS Secretary Alex Azar); the Florida Board of Medicine, Florida Council of 100, and the Board of Trustees of Nova Southeastern University. Also served on the Florida Board of Governors, which oversees 11 public universities in Florida, for seven years; the National Heart, Lung and Blood Institute at NIH, as a member of the U.S. delegation to the World Health Organization in Geneva, Switzerland, and as President of the Fort Lauderdale Heart Institute at Holy Cross Hospital

  • Former Director of Ivax (acquired by Teva Pharmaceutical (NYSE: TEVA) for $7.4 billion

  • Co-authored several scientific papers, and participated in various clinical trials


Rohan Hoare, PhD

SAB Member

  • Proven leader with demonstrated success in the medical device industry. Skilled in Market Development, Commercialization, Strategy, Product Development, Clinical Research, Quality and Manufacturing

  • Career highlights spanning over 35 years include: 9 years at Neuromodulation Division at St. Jude Medical, culminating in President role; COO at Cyberonics/President Neuromodulation LivaNova, 10 years at McKinsey & Company; 3 years as President & CEO of EndoStim; and 3 years as Emergency Service Officer for the National Safety Council of Australia

  • Serves on the Board of Nexstim, Helsinki, Finland

  • PhD in Physics from Harvard University and a BS (Hons), Physics from Monash University

Luis Salmun 2 - US - Square.jpg

Luis M. Salmun, MD

SAB Member

  • Over three decades experience in medicine and medical affairs, research, clinical, healthcare insurance, and regulatory registration and approvals; with specialties that include Immunology and Allergy, Asthma, COPD, Cardiovascular Disease, Diabetes and Pediatrics

  • Former Instructor, Harvard Medical School; Medical Advisor, Asthma & Allergy Foundation of America

  • Career highlights include: Sr. Vice President, Global Medical Affairs, DBV Technologies; Executive Director, Health Science Executives / Head, Health Science Executives, Boehringer-Ingelheim; Vice President & National Practice Leader, Pulmonary and Immunology – Therapeutic Resource Centers, Medco Health Solutions; Executive Director, Medical Affairs, Mylan (Medical Affairs global responsibilities for the EpiPen auto-injector franchise); Executive Director, WorldWide Consumer Medicines, Bristol-Myers Squibb Company; Sr. Director, Consumer Health Care, Schering-Plough Corporation 

  • Widely published, including New England Journal of Medicine, Journal of Allergy and Clinical Immunology, Clinical Therapeutics, Immunology News, Medico Interamericano, and Annals of Allergy and Clinical Immunology. 


AJ Redmer, B.S., B.A.

SAB Member

  • A global thought leader and product marketing expert in the areas of consumer products, global marketing, direct sales, technology, software, big data, and gamification

  • Helped mastermind the development and global launch of the Xbox 360; Armed with a $19 Billion budget he helped steer the Xbox franchise into one of most successful consumer product launches in history

  • Career highlights include executive leadership positions at Microsoft, Nintendo, Lucasfilm (Star Trek franchise), Spectrum Holobyte and currently President of Redmer Productions

  • Designed and/or oversaw the development of some of the most well-known franchises in the Games industry including; SimCity, Star Wars, Indiana Jones, Tetris, Ridge Racer, Pokémon, Flight Simulator, Age of Empires, Project Gotham Racing and Forza Motorsport, with a combined adoption totaling almost one Billion users

  • Worked in and oversaw operations in multiple countries on all four continents, including the US, Europe, Latin America, Japan, China, Australia, South Korea and Singapore

  • Participated in five significant exits, of which three were acquisitions and two were IPOs


Xi Wang, MD, PhD

SAB Member

  • Almost three decades experience with a rare combination of clinical, research, business and medical affairs experiences in both small and large biopharmaceutical industry settings, with specialties including in COPD, Asthma and IPF, CardioMetabolic Diseases, hypertension and bronchoconstrictive diseases, and cardiac physiology, pharmacology and pathology

  • A comprehensive understanding of healthcare systems and PhRMA code; Strong ability to interact with national and regional key opinion leaders (KOLs), academic investigators, individual healthcare providers, organized customer, payers and internal team members

  • Career highlights include: Medical Director, Field Group, Pfizer; Senior Medical Science Liaison, Sanofi Genzyme; Senior Medical Science Liaison, Mallinckrodt Pharmaceuticals; and Associate Director, Health Science Executive, Boehringer Ingelheim Pharmaceuticals

  • Bilingual: fluent in English and Mandarin

© 2020 Kwivik Therapeutics, Inc.